Literature DB >> 28283688

Comments on Diez-Perez et al.: Recommendations for the screening of adherence to oral bisphosphonates.

Y H Zhou1,2,3, Z F Sheng4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28283688     DOI： 10.1007/s00198-017-3987-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  9 in total

1.  The potential value of monitoring bone turnover markers among women on alendronate.

Authors:  Katy J L Bell; Andrew Hayen; Les Irwig; Marc C Hochberg; Kristine E Ensrud; Steven R Cummings; Douglas C Bauer
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  Age- and BMD-related differences in biochemical markers of bone metabolism in rural and urban women from Lublin Region, Poland.

Authors:  Rafał S Filip; Jerzy Zagórski
Journal:  Ann Agric Environ Med       Date:  2004       Impact factor: 1.447

3.  Age-related changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and the relationship with bone mineral density in Chinese women.

Authors:  Peng-Fei Shan; Xian-ping Wu; Hong Zhang; Xiang-hang Luo; Xing-Zhi Cao; Hui Xie; Shi-Ping Liu; Yin-Zheng Pi; Tuan-Yu Fang; Hong Liu; Zhi-Heng Chen; Ni Zhong; Er-Yuan Liao
Journal:  Clin Chim Acta       Date:  2005-12-05       Impact factor: 3.786

4.  International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.

Authors:  A Diez-Perez; K E Naylor; B Abrahamsen; D Agnusdei; M L Brandi; C Cooper; E Dennison; E F Eriksen; D T Gold; N Guañabens; P Hadji; M Hiligsmann; R Horne; R Josse; J A Kanis; B Obermayer-Pietsch; D Prieto-Alhambra; J-Y Reginster; R Rizzoli; S Silverman; M C Zillikens; R Eastell
Journal:  Osteoporos Int       Date:  2017-01-16       Impact factor: 4.507

5.  Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study.

Authors:  Masayuki Iki; Takashi Akiba; Toshio Matsumoto; Harumi Nishino; Sadanobu Kagamimori; Yoshiko Kagawa; Hideo Yoneshima
Journal:  Osteoporos Int       Date:  2004-07-31       Impact factor: 4.507

6.  Association between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosis.

Authors:  Takafumi Majima; Akira Shimatsu; Yasato Komatsu; Noriko Satoh; Atsushi Fukao; Kiyoshi Ninomiya; Tadashi Matsumura; Kazuwa Nakao
Journal:  Endocr J       Date:  2008-01-10       Impact factor: 2.349

Review 7.  Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw.

Authors:  Sanford Baim; Paul D Miller
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

8.  Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study.

Authors:  K E Naylor; R M Jacques; M Paggiosi; F Gossiel; N F A Peel; E V McCloskey; J S Walsh; R Eastell
Journal:  Osteoporos Int       Date:  2015-05-20       Impact factor: 4.507

9.  Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.

Authors:  Mei Li; Yan Li; Weimin Deng; Zhenlin Zhang; Zhongliang Deng; Yingying Hu; Weibo Xia; Ling Xu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240
  9 in total
  1 in total

1.  Recommendations for the screening of adherence to oral bisphosphonates: reply to comments by Zhou and Sheng.

Authors:  R Eastell; A Diez-Perez
Journal:  Osteoporos Int       Date:  2017-03-10       Impact factor: 4.507
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.